Correspondence 0001628280-24-040600 from LENZ Therapeutics, Inc. (LENZ)
LENZ Therapeutics, Inc.
Date: Sept. 17, 2024 · CIK: 0001815776 · Accession: 0001628280-24-040600
AI Filing Summary & Sentiment
File numbers found in text: 333-282036
Letter
Document
September 17, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-3720
Attention: Tim Buchmiller
Re: LENZ Therapeutics, Inc.
Registration Statement on Form S-1
File No. 333-282036
Acceleration Request
Requested Date: September 19, 2024
Requested Time: 4:00 p.m. Eastern Time, or as soon thereafter as practicable
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, LENZ Therapeutics, Inc. (the “Company”) hereby requests that its Registration Statement on Form S-1 (File No. 333-282036) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Ben Capps at (858) 350-2237.
Sincerely,
LENZ THERAPEUTICS, INC.
Show Raw Text
CORRESP 1 filename1.htm Document September 17, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-3720 Attention: Tim Buchmiller Re: LENZ Therapeutics, Inc. Registration Statement on Form S-1 File No. 333-282036 Acceleration Request Requested Date: September 19, 2024 Requested Time: 4:00 p.m. Eastern Time, or as soon thereafter as practicable Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, LENZ Therapeutics, Inc. (the “Company”) hereby requests that its Registration Statement on Form S-1 (File No. 333-282036) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Ben Capps at (858) 350-2237. Sincerely, LENZ THERAPEUTICS, INC. By: /s/ Evert Schimmelpennink Evert Schimmelpennink Chief Executive Officer cc: Daniel Chevallard, LENZ Therapeutics, Inc. Dan Koeppen, Wilson Sonsini Goodrich & Rosati Ben Capps, Wilson Sonsini Goodrich & Rosati